Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Manchester United PLC (MANU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Manchester United PLC — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B), while Manchester United PLC trades at $20.68 (market cap $3.55B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 2× Manchester United PLC's market cap, and Manchester United PLC pays a 1.26% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Manchester United PLC for 109 Days on average.
| IONS | MANU | |
|---|---|---|
Market Cap | $7.10B | $3.55B |
Volume | 2,027,457 | 311,271 |
Sector | Health | Media |
52-Week High | $86.50 | $24.19 |
52-Week Low | $42.38 | $15.20 |
Typical Hold Time | 0 Days | 109 Days |
Enterprise Value | $6.66B | $4.38B |
Dividend Yield | — | 1.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Manchester United (MANU) trades at $21.08, up 1.2% with a bullish technical signal despite negative profitability metrics. The stock shows mixed earnings performance with recent beats but negative net income margins. Revenue reached $666.51M in 2025, though the company continues to post losses. Analyst sentiment is divided with 40% buy ratings, while technical indicators suggest potential near-term support at $21.
The investment case hinges on franchise valuation upside versus operational challenges. While trading at a discount to Forbes' $7.2B valuation estimate, persistent losses and high debt levels present significant risks. Champions League qualification offers revenue potential, but profitability remains elusive amid competitive pressures in European football.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →
